| European Case Law Identifier: | ECLI:EP:BA:1991:T049589.19910109 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Date of decision: | 09 January 1991 | ||||||||
| Case number: | T 0495/89 | ||||||||
| Application number: | 80301356.4 | ||||||||
| IPC class: | C12P 1/00 | ||||||||
| Language of proceedings: | EN | ||||||||
| Distribution: | |||||||||
| Download and more information: |
|
||||||||
| Title of application: | Monoclonal antibody to human helper T cells, method of preparing it, hybrid cell line producing it, its diagnostic and therapeutic uses and diagnostic and therapeutic compositions comprising it. | ||||||||
| Applicant name: | Ortho Pharmaceutical Corp. | ||||||||
| Opponent name: | 1) Biotest-Serum-Inst. 2) Behringwerke 3) Becton, Dickinson 4) Sandoz AG 5) Boehringer Mannheim |
||||||||
| Board: | 3.3.02 | ||||||||
| Headnote: | - | ||||||||
| Relevant legal provisions: |
|
||||||||
| Keywords: | Sufficient disclosure (no) Culture deposit not corresponding to the written disclosure |
||||||||
| Catchwords: |
- |
||||||||
| Cited decisions: |
|
||||||||
| Citing decisions: |
|
||||||||
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t890495eu1.html
Date retrieved: 17 May 2021